SBL
CRBU icon

Sargent Bickham Lagudis’s Caribou Biosciences CRBU Stock Holding History

Sargent Bickham Lagudis’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.02K Hold
162
– – ﹤0.01% 968
2022
Q3 		$2K Hold
162
– – ﹤0.01% 877
2022
Q2 		$1K Buy
+162
New +$1.24K ﹤0.01% 976

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sargent Bickham Lagudis's CRBU Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Caribou Biosciences (CRBU) position steady in Q4 2022 at 162 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #968.

Sargent Bickham Lagudis first reported a position in CRBU in Q2 2022 and has held it in 3 quarters since. The position peaked at $2K in Q3 2022. 133 funds tracked by Wall St. Rank hold CRBU as of Q4 2022.

  • Sargent Bickham Lagudis held 162 shares of Caribou Biosciences worth $1.02K as of Q4 2022.
  • Sargent Bickham Lagudis left its Caribou Biosciences share count unchanged in Q4 2022.
  • Caribou Biosciences made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #968 holding.
  • Sargent Bickham Lagudis first reported a position in Caribou Biosciences in Q2 2022 and has held it in 3 quarters since.
  • Sargent Bickham Lagudis's Caribou Biosciences position peaked at $2K in Q3 2022.
  • 133 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.